#輪生逆轉勝

#花蓮慈濟醫院 與 #尖端醫 合作的 #自體骨髓間質幹細胞治療脊髓損傷申請計畫，是 臺灣第一個取得衛生福利部核可用在臨床上神經損傷的療法。
The Clinical Trial of # Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) for #SpineInjury , which is held by #Hualien Tzu Chi Hospital and #Taiwan Advance Bio-Pharmaceutical Inc. , is the first clinical therapy approved by the Ministry of Health and Welfare (MOHW) to treat neurological injury.
-----
自體骨髓間質幹細胞治療脊髓損傷申請計畫收案標準，包含脊髓損傷診斷後6個月，且神經學檢查顯示至少持續1個月無進展的穩定結果、神經損傷水平爲第七頸椎至第二腰椎之間、ASIA神經學分級爲A級（下肢全癱及肛門無感覺）等，諮詢專線：03-8561825#18939。
The criteria for the project of Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) for spine injury including those patient whom was diagnosed to have spine injury for more than 6 months and the neurological examination showed no improvement constantly for at least one month; the injured site is located from 7th cervical spinal cord till 2nd lumbar spinal cord; Level A of ASIA Impairment Scale（Paraplagia with Numbness of Anus）Call Service: 03-8561825#18939
-----
「人生成為了『輪』生」，2016年的一場車禍，造成簡先生的胸椎第5、6節脊髓損傷，胸部以下癱瘓，沒有知覺，也不會痛，上廁所得自行導尿。2021年11月從南投盤山過嶺來到花蓮慈院接受自體骨髓間質幹細胞回輸手術，術後十天，下半身還是無法使力，也無知覺，但之後在簡先生一週六天、每天四小時的積極復健，與簡媽媽巧手DIY復健器材及細心陪伴下，傳來了讓振奮人心的好消息。
Life with wheelchair-bound. It happened in 2016, a car accident causing Mr. Jian’s spinal cord injured on thoracic spine no. 5 & 6, that result in paralysis happened below his chest, came along with numbness & painless, he was forced to do self-urine catheterization thereafter. He came a long way from Nantou county and received autologous bone marrow-derived mesenchymal stem cells transplantation in Hualien Tzu Chi Hospital in November, 2021. 10 days after the surgery, he still felt numbness below chest level and could not exerting strength. However, with the aggressive rehabilitation (four hours a day, six days a week ), also with aid from her mother’s handmade walker and caring companion, there was an exciting news at last.


拿著助行器，緩緩一步步往前走，他是花蓮慈院與尖端醫合作自體骨髓間質幹細胞治療脊髓損傷申請計畫的第一例簡先生，今年26歲的他其實在八個月以前，還是位下半身沒有知覺的脊髓損傷病友，在2021年11月完成自體骨髓間質幹細胞回輸手術及積極復健後，原本無知覺的下半身，已慢慢找回感覺，迎向他的「輪生逆轉勝」。
Mr. Jian plodded slowly forward with the walker, and he is the first case applied for the clinical trial of Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) for Spine Injury, a collaboration project of both Hualien Tzu Chi Hospital and Taiwan Advance Bio-Pharmaceutical Inc.
He is 26 years old and actually was a patient diagnosed as spinal cord injury with paraplegia for 8 months in the past. After the autologous bone marrow-derived mesenchymal stem cells transplantation with aggressive rehabilitation, he gradually regained the feeling and movement of the lower part of his body, it leads to his new life reversed from the wheelchair.